Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo

Proceedings of the National Academy of Sciences of the United States of America

Volumn 96, Issue 14, 1999, Pages 8247-8252

  Clish, C B ^a   O'Brien, J A ^a   Gronert, K ^a   Stahl, G L ^a   Petasis, N A ^a   Serhan, C N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 EPI 16 (4 FLUORO)PHENOXY LIPOXIN A4; ACETYLSALICYLIC ACID; ASPIRIN TRIGERRED LIPOXIN A4; CYCLOOXYGENASE 2; DEXAMETHASONE; FATTY ACID DERIVATIVE; LEUKOTRIENE B4; LIPOXIN A; PROSTAGLANDIN B2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; IMMUNOMODULATION; INFLAMMATORY INFILTRATE; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE MIGRATION INHIBITION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; SKIN INFLAMMATION; TOPICAL DRUG ADMINISTRATION;

ANIMALS; ASPIRIN; CHEMOTAXIS, LEUKOCYTE; EAR; HYDROXYEICOSATETRAENOIC ACIDS; LIPOXINS; MALE; MICE; MICE, INBRED BALB C; NEUTROPHILS; RECOMBINANT PROTEINS; SKIN; SKIN PHYSIOLOGY; STEREOISOMERISM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033529195     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.96.14.8247     Document Type: Article

References (31)